SIAH1/CTR9 axis promotes the epithelial-mesenchymal transition of hepatocellular carcinoma
Zhiyi Liu1,2,3, Pengchao Luo1,2,3, Kuan Cao1,2,3
1Research Center of Digestive Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Abstract:
SIAH1 has been reported to participate in several human cancers, including hepatocellular carcinoma (HCC). However, the effect of SIAH1 on the epithelial-mesenchymal transition (EMT) has not been reported in HCC cells. Here, we discovered the inhibitory effect of SIAH1 on HCC cell migration and invasion, which was related with regulating EMT. Molecularly, a yeast two-hybrid experiment indicated that Cln Three Requiring 9 (CTR9) was a potential interacting protein of SIAH1, which was further verified by co-immunoprecipitation assays. Furthermore, SIAH1 inhibited the EMT of HCC cells through negatively regulating CTR9. Importantly, CTR9 was ubiquitinated and degraded by SIAH1 via the proteasome pathway in HCC cells. Additionally, it was showed that SIAH1 mainly mediated the K48-linked polyubiquitination on CTR9. Finally, the protein level of CTR9 was found to be inversely correlated with SIAH1 in human HCC tissues. Summed up all together, these findings reveal that SIAH1/CTR9 axis promotes the EMT of HCC cells and is a promising therapeutic target for HCC therapy.
Insights
The study reveals that SIAH1 inhibits hepatocellular carcinoma (HCC) cell migration and invasion by regulating epithelial-mesenchymal transition (EMT). SIAH1 targets CTR9 for degradation, impacting EMT and offering a potential therapeutic strategy for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- SIAH1 is implicated in various human cancers, including hepatocellular carcinoma (HCC).
- The role of SIAH1 in regulating epithelial-mesenchymal transition (EMT) in HCC remains largely unexplored.
- EMT is a critical process involved in cancer cell migration and invasion.
Purpose of the Study:
- To investigate the effect of SIAH1 on EMT in HCC cells.
- To identify interacting partners of SIAH1 in HCC.
- To elucidate the molecular mechanism by which SIAH1 influences HCC progression.
Main Methods:
- Yeast two-hybrid screening to identify SIAH1 interacting proteins.
- Co-immunoprecipitation assays to validate protein interactions.
- Analysis of ubiquitination and proteasomal degradation pathways.
- Western blotting to assess protein levels in HCC tissues.
Main Results:
- SIAH1 inhibits HCC cell migration and invasion by regulating EMT.
- CTR9 (Cln Three Requiring 9) was identified as a direct interacting protein of SIAH1.
- SIAH1 promotes EMT by negatively regulating CTR9 through K48-linked polyubiquitination and proteasomal degradation.
- CTR9 protein levels are inversely correlated with SIAH1 levels in human HCC tissues.
Conclusions:
- The SIAH1/CTR9 axis plays a crucial role in promoting EMT in HCC cells.
- Targeting the SIAH1/CTR9 interaction presents a potential therapeutic strategy for HCC.
- Understanding this axis provides insights into HCC progression and metastasis.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation
MAPK Signaling Cascades


